Voyager Therapeutics Inc (VYGR)
8.81
+0.28
(+3.28%)
USD |
NASDAQ |
May 03, 16:00
8.81
0.00 (0.00%)
After-Hours: 20:00
Voyager Therapeutics 1 Year Total Returns (Daily): 14.27% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | 14.27% |
May 02, 2024 | 22.91% |
May 01, 2024 | 15.47% |
April 30, 2024 | 7.86% |
April 29, 2024 | 7.17% |
April 26, 2024 | 2.42% |
April 25, 2024 | -1.33% |
April 24, 2024 | -1.69% |
April 23, 2024 | -4.02% |
April 22, 2024 | -5.02% |
April 19, 2024 | -5.18% |
April 18, 2024 | -3.45% |
April 17, 2024 | -2.27% |
April 16, 2024 | -1.12% |
April 15, 2024 | 2.11% |
April 12, 2024 | 7.80% |
April 11, 2024 | 10.03% |
April 10, 2024 | 9.96% |
April 09, 2024 | 13.77% |
April 08, 2024 | 13.39% |
April 05, 2024 | 21.17% |
April 04, 2024 | 18.42% |
April 03, 2024 | 15.15% |
April 02, 2024 | 28.53% |
April 01, 2024 | 36.71% |
Date | Value |
---|---|
March 28, 2024 | 32.24% |
March 27, 2024 | 31.68% |
March 26, 2024 | 35.96% |
March 25, 2024 | 25.64% |
March 22, 2024 | 21.59% |
March 21, 2024 | 20.82% |
March 20, 2024 | 33.89% |
March 19, 2024 | 27.02% |
March 18, 2024 | 14.77% |
March 15, 2024 | 15.71% |
March 14, 2024 | 10.13% |
March 13, 2024 | 16.14% |
March 12, 2024 | 20.88% |
March 11, 2024 | 20.48% |
March 08, 2024 | 15.25% |
March 07, 2024 | 28.61% |
March 06, 2024 | 15.95% |
March 05, 2024 | 24.49% |
March 04, 2024 | 31.87% |
March 01, 2024 | 31.29% |
February 29, 2024 | 15.88% |
February 28, 2024 | 24.93% |
February 27, 2024 | 24.44% |
February 26, 2024 | 21.86% |
February 23, 2024 | 18.21% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-78.22%
Minimum
Oct 05 2021
278.2%
Maximum
Jan 13 2023
6.26%
Average
1.88%
Median
Feb 20 2024
1 Year Total Returns (Daily) Benchmarks
Ligand Pharmaceuticals Inc | -2.03% |
United Therapeutics Corp | 20.15% |
MEI Pharma Inc | -38.56% |
Agios Pharmaceuticals Inc | 51.03% |
Macrogenics Inc | 127.4% |